Vitamin D and Obesity by Gacem, Sabrina Ait & Shahwan, Moyad Jamal
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
1Chapter
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Abstract
Obesity is a very common issue worldwide, and it is one of the risk factors for 
mortality. Several studies were done to identify the causes of this issue and to inves-
tigate factors that can affect this condition. Vitamin D is claimed to have an impact 
not only for maintaining bone health but also for having an association between 
its deficiency and obesity as some studies found that the concentrations of this 
vitamin are low in obese individuals. The suggested mechanisms and a discussion 
of the latest findings as well as the possibility of integrating supplementation in the 
treatment of obesity are covered in this book chapter. It was concluded that vitamin 
D deficiency is prevalent in many parts of the world and the supplements are an 
affordable option, but further studies are required to address different confounding 
factors that will result in clear data interpretation and will contribute to the future 
planning of health policies and guidelines used by healthcare professionals.
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1. Introduction
Obesity is one of the most commonly observed health issues and can be defined 
as the condition in which there is an abnormal or excess fat accumulation in the 
body that can affect the health of an individual [1].
A measure of the obesity and other body weight status is the body mass index 
(BMI) which is a tool that uses the weight and the height of an individual. The 
weight is divided by the square of the height. If the BMI is 30 or more, the indi-
vidual will be considered obese. BMI provides a measure of obesity and overweight 
that is general for female and male adults from different age groups, but for children 
the age has to be taken into consideration. Due to its inconsistent representation 
and correspondence for the level of fat in various individuals, it should be used as a 
rough guide [1].
According to the World Health Organization (WHO), obesity is known to be 
high especially in developed countries (high-income countries), but recently it 
was observed to increase even in middle- and low-income countries as well which 
is a serious issue because obesity is one of the main risk factors for several seri-
ous chronic diseases that are noncommunicable diseases (NCDs) like respiratory 
diseases, cardiovascular diseases, diabetes, and cancers causing an estimated 38 
million deaths annually according to the WHO statistics [1].
According to the Global Health Observatory (GHO), data from the WHO sta-
tistics of the prevalence of obesity among adults aged 18+ (1975–2016) represented 
27.8% in the United Kingdom (UK) and 31.7% in the United Arab Emirates (UAE) 
among adults [1]. According to the National Health Survey, adult obesity in the UAE 
stands at 27.8% in 2019 [2]. Obesity is caused by several reasons, and one of them is 
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the imbalance between calories expended and calories consumed due to changes in 
physical activity and dietary patterns [3].
The prevalence of obesity was found to be due to several factors especially 
change in lifestyle habits besides the genetic contribution and other factors, and this 
indicates that certain healthcare awareness activities and certain interventions can 
help and contribute to overcome this issue [4].
Vitamin D is a very important vitamin and plays a role in the maintenance of bone 
tissues, the balance of phosphorus and calcium, as well as other cell functions [5].
During sunlight exposure, the skin is penetrated by ultraviolet B photons by 
which pre-vitamin D3 is isomerized into vitamin D3 by the body heat [6].
Although many controversies still exist suggesting that vitamin D is not con-
nected to any health condition and it is just a marker of general good health, there 
is also a good evidence of the relation between vitamin D level and malignancies as 
well as mental health, bone health, and other health issues [7].
Vitamin D has a vital role in maintaining good health, and its benefits or impor-
tance comes from its role in absorbing calcium and phosphorus from the gastro-
intestinal track, which is why it can be used to treat and prevent bone and muscle 
aches as well as chronic fatigue, teeth and dental problems, and osteoporosis [8].
Vitamin D deficiency contributes to many chronic metabolic and endocrine 
diseases [9, 10]. Vitamin D deficiency causes rickets and growth retardation and 
an enhanced risk of adult fractures [11, 12]. Obesity was found to be significantly 
associated with low calcium serum levels especially abdominal obesity [13, 14].
It is also associated with other conditions such as enhanced risk of common 
cancers, infectious conditions, cardiovascular diseases, and other diseases [15, 16].
In a recent study of 2018, it was observed that vitamin D supplements only 
increase bone density in adults with 25-hydroxyvitamin D ≤ 30 nmol/L, and the 
study suggested the implementation or use of supplements [17].
Vitamin D deficiency is connected as well to high myocardial diseases and 
cardiovascular risk; however, the way it works is yet to be investigated in further 
details [18]. A recent study held in 2018 showed a significant association between 
low plasma vitamin D levels and prevalence of hypertension. There was a statisti-
cally significant correlation between vitamin D deficiency and acute coronary 
syndrome [19].
On the other hand, a study found that the supplementation of calcium in addi-
tion to vitamin D did not diminish the danger of chronic heart disease or stroke and 
did not have an effect on the incident of hypertension [20, 21].
Several patients with low vitamin D level remain undetected, with bone chem-
istry values within the reference ranges, unless clinical suspicion is raised. Clinical 
suspicion based on history and awareness of risk factors should remain the gold 
standard for requesting vitamin D measurements [22].
2. Suggested mechanisms of action
The body obtains energy from the ingested food, and part of this energy is 
utilized to maintain the regular body activities while the other part can be stored 
in the adipose tissue that is able to sense the body energy state. When the body has 
excess energy compared to the demand, the adipose tissue starts to store the energy 
as triglyceride in the lipid droplets [23, 24].
The process of lipolysis in which the triglycerides get broken into free acids 
is activated by catecholamines by the cAMP signaling pathway which activates 
the protein kinase A. The hormone-sensitive lipase enzyme (HSL) that promotes 
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the translocation of lipid droplet which will lead to access to triglyceride stores is 
phosphorylated by protein kinase A [24, 25].
The activity of the proteins can be changed after being formed through a mecha-
nism called phosphorylation. A phosphate group which is provided by ATP is added 
to a protein by enzymes referred to as kinases [24].
When the body requires energy, lipolysis occurs. The adipose triglyceride lipase 
(ATGL) enzyme starts hydrolyzing the triglycerides into diacylglyceride. The 
diacylglyceride is then broken down into monoglyceride by the enzyme hormone-
sensitive lipase (HSL), and then the monoglyceride ester bond is cleaved to release 
glycerol [24, 26].
The lipid droplets in the fat-storing cells in adipose tissue are coated by a protein 
called perilipin which acts as a protective coat from the body’s natural lipases like 
hormone-sensitive lipase (HSL) that breaks triglycerides into glycerol and free 
fatty acids for use in metabolism during lipolysis. Phosphorylation of perilipin is 
important for the mobilization of fats in adipose tissue which is important for the 
regulation of lipid storage [27].
Insulin suppresses the enzyme hormone-sensitive lipase (HSL) and adipose 
triglyceride lipase (ATGL) as well because insulin enhances the amount of perilipin 
around the lipid droplets to prevent their access to triglycerides [24].
Vitamin D deficiency is known to occur due to several reasons and through 
several mechanisms, and one of the stated reasons is the low sun exposure due to 
decreased mobility due to obesity [14, 24].
Vitamin D is obtained from different sources taken up by the adipose tissue that 
was suggested to store this vitamin for conditions when the production is reduced. 
The levels of adipose tissue are inversely correlated with this vitamin level [28].
Several hypotheses were proposed to correlate obesity with vitamin D defi-
ciency, and few of which are due to low physical activities and other reasons which 
led to limited sun exposure. There was evidence that vitamin D storage, action, and 
metabolism influences adiposity, and an observational study had shown that there 
is an increased risk of deficiency among obese individuals, but detailed explained 
causes are not clear [29].
The hormonal form of vitamin D is (1,25 dihydroxyvitamin D), and besides its 
known action in the regulation of calcium level, the vitamin D hormone has many 
other activities such as the regulation of adipocytes [24].
Another hypothesis suggested that the level of vitamin D stimulation enzyme 
1-α-hydroxylase in the adipose cells may explain the greater local use of 25(OH)D.
Medical practitioners measure the level of this metabolite to identify a patient’s 
vitamin D status [30, 31]. 25-Hydroxyvitamin D (25(OH)D) is also known as cal-
cifediol, which is a prehormone produced in the liver by hydroxylation of vitamin 
D3 (cholecalciferol) by the enzyme cholecalciferol 25-hydroxylase. Vitamin D3 
gets converted into calcifediol, and this process takes approximately 7 days; then 
calcifediol is converted in the kidneys (by the enzyme 25(OH)D-1α-hydroxylase) 
into calcitriol (1,25-(OH)2D3), a secosteroid hormone that is the active form of 
vitamin D [32].
Variations in serum 25(OH)D and vitamin D reserves can be directly linked 
to the amount of subcutaneous body fat according to this hypothesis [10, 33]. 
However, in a cohort study, it was reported that this theory was not enough to 
address the relationship between vitamin D deficiency and obesity [10, 33].
The active form of vitamin D (1,25-dihydroxyvitamin D) can affect the free 
fatty acid mobilization from the adipose tissue [34]. Animal studies found that high 
doses of vitamin D can lead to elevation in energy expenditure because of uncou-
pling of oxidative phosphorylation in adipose tissues [35].
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It has also been suggested that the weather may contribute as obesity can result 
from an adaptive winter action and vitamin D obtained from the sun is limited 
during winter which can play a role in the tendency to elevate fat mass during cold 
weather [36].
Another theory for the correlation between obesity and vitamin D could be 
that vitamin D is stored in the adipose tissue, and, hence, perhaps the most likely 
explanation is that the bigger the storage capacity for this vitamin in obese people, 
the less the circulating [25(OH)D] concentrations in the blood [37].
Another suggested association was between genetic variants that imitate the 
impact of modifiable environmental exposure and the outcome of interest [38].
A genetic variant linked with lower 25(OH)D concentrations should be linked 
with BMI if lower vitamin intake is causally linked to obesity. The genetic associa-
tions are considered less subjected to confounding factors and socioeconomic and 
lifestyle factors as genotypes are invariant [39].
Different researches on vitamin D had been made based on the fact that several 
human cell types carry vitamin D receptor (VDR) which can contribute to several 
cell functions and regulation [40].
The role of vitamin D receptor (VDR) in the regulation of body energy in vivo 
was explained in previous studies, and it was observed that when these receptors 
were inhibited in some animal studies, several body tissues were affected, which 
made it difficult to interpret the data and make a clear correlation [24, 41]. Some 
studies suggested that 1.25(OH)D inhibits adipogenesis through actions modulated 
by vitamin D-dependent receptors, so the decrease in vitamin D can lead to exces-
sive differentiation of pre-adipocytes to adipocytes [10, 42].
It was observed in some studies that obese participants who were subjected to a 
dose of ultraviolet (UV-B) radiation showed a small response compared to normal-
weight participants [37, 40].
The detailed mechanism explaining how this vitamin might be kept in fat was 
not clearly mentioned, but although the previous mechanism is not detailed, it 
suggested that vitamin D is relatively tightly bound in tissue depots and not appro-
priately released to maintain the serum vitamin amount in the blood [40].
Several different levels of sun exposure are not a likely explanation for the 
link between adiposity and vitamin D deficiency as observed in some studies. 
Alternatively, it was suggested that extra fat holds the vitamin D metabolites and 
that the cholecalciferol is partially sequestered by the fat before being transported 
to the liver for the first hydroxylation [10, 37].
A study concluded that vitamin D serum levels were observed to be (53%) lower 
among obese participants. Some studies suggested that vitamin D deficiency can favor 
higher adiposity by promoting elevated parathyroid hormone levels and more calcium 
inflow into adipocytes which will increase lipogenesis through which acetyl-CoA is 
converted to triglyceride for storage in fat and packaged within lipid droplets [10, 43].
Identifying and understanding the mechanism beyond low vitamin D status in 
obesity has a great importance in deciding on appropriate vitamin D replacement 
doses for obese individuals [40].
However, further studies are required to clarify further the mechanism and the con-
founding factors that may interfere with the data interpretation such as physical activity, 
educational level, diet intake, secondary hyperparathyroidism, and other factors.
3. Vitamin D and obesity findings
Several studies were done to identify the causes of obesity and to investigate 
factors that can affect this condition. Vitamin D is claimed to have an impact not 
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only for maintaining bone health but also for having an association between its 
deficiency and obesity as some studies found that the concentrations of this vitamin 
are low in obese individuals.
Although many controversies still exist suggesting that vitamin D is not con-
nected to any health condition and it is just a marker of general good health, there 
is also a good evidence of the relation between vitamin D level and several health 
conditions [7].
It was observed in many studies including a meta-analysis study that vitamin D 
concentrations were linked to the decrease in the risk of occurrence of metabolic 
syndrome, diabetes, and cardiovascular diseases [10, 26].
Several studies have shown a positive correlation such as some observational 
studies that showed a correlation between vitamin D deficiency and obesity with no 
clear evidence for the detailed causes [9, 10, 44, 45].
Results of a meta-analysis study showed that the deficiency of this vitamin was 
linked with obesity regardless of the age of participants, and it was concluded that 
there was no significant correlation with age and many studies were held to assess 
the increasing risk of developing metabolic syndrome and other disorders like 
hypertension, excess weight, and cancer with vitamin D deficiency [9, 10, 46].
A recent meta-analysis study revealed as well no significant correlation with 
latitude or the development status of the country, so it can be concluded that it was 
found that the correlation between vitamin D deficiency and obesity is not affected 
by latitude, country status, or age, but a positive association between body mass 
index (BMI) and vitamin D deficiency was observed and due to the study designs 
included, it was difficult to clarify the underlying causes [7, 47].
It was concluded from some studies that investigated the relation between 
vitamin D status and body mass index that on the basis of a bidirectional genetic 
approach that reduces confounding, a bigger BMI leads to lower 25(OH)D and 
decreasing BMI is expected to reduce the prevalence of vitamin D deficiency. When 
obese and nonobese participants were given 50,000 IU of vitamin D orally or 
exposed to simulated sunlight, the results showed that the obese participants were 
able to increase the vitamin blood levels by no more than 50% compared with other 
participants, and this was explained that it is because the body fat sequesters the 
fat-soluble vitamin which makes obese individuals at higher risk [48, 49].
Similar results were observed in another study that the observed serum vitamin 
D3 levels in obese individuals were less than that in normal-weight individuals and 
blood vitamin D2 concentrations after the intake of 50,000 IU of vitamin D2 are 
inversely correlated with BMI [37].
Similarly, another study concluded that obesity is linked with a lower bioavail-
ability cutaneous synthesized vitamin D and dietary intake which was explained 
similarly to be due to the sequestration of vitamin D into the adipose tissue [50].
Similarly, other researches have shown that obese individuals tend to have lower 
blood concentrations of vitamin D3 and 25(OH)D3 than those with normal weights 
[51–53]. Several studies including epidemiological studies showed a high prevalence 
increased BMI and low vitamin D status [33, 54–59].
On the other hand, other researches revealed a weak correlation between 
vitamin D concentrations, and BMI a negative correlation between anthropometric 
variables and vitamin D level from different races and age groups [10, 47].
4. Integration of vitamin D in obesity treatment
Obesity is caused by many factors, but despite the genetic contribution, it was 
observed to occur mainly due to lifestyle habits, which indicates that it can be 
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modified through some interventions or health awareness campaigns. The WHO 
has identified physical inactivity and unhealthy diet as one of the risk factors for 
noncommunicable diseases (NCDs), and it urges all efforts to contribute in reduc-
ing them to prevent deaths from NCDs [45].
Identifying and understanding the mechanism beyond low vitamin D status 
in obesity has a great importance in deciding the needed and required vitamin D 
replacement doses for obese individuals [40].
A study discussed the possibility of integrating vitamin D supplementation 
with current strategies, and it was suggested that the induction of adipocyte death 
through apoptosis is a very promising strategy to manage obesity [60–62].
When the adipocytes reach a maximum size, elevation in adipose tissue mass 
includes as well an elevation in adipocyte number. So, weight loss can result from 
not only a decrease in adipocyte size but also adipocyte number and can result 
in the loss of adipose tissue mass. The removal of adipocytes by a process called 
apoptosis decreases body fat and can contribute to the long-lasting control of 
weight loss [60–62]. The effects of the hormonal form of vitamin D, 1,25(OH)2D3, 
on apoptotic cell death are mediated through several signaling pathways on cellular 
calcium Ca2+ [60–62].
High calcium and vitamin D3 intake is linked to the stimulation of the calcium-
dependent apoptotic proteases in adipose tissue. The 1,25(OH)2D3-induced 
cellular calcium signal acts as an apoptotic initiator that directly recruits calcium-
dependent apoptotic effectors that are able of causing apoptosis in adipose tissue. 
It was observed that 1,25(OH)2D3 induces a prolonged elevation in intracellular 
calcium concentration (the apoptotic Ca2+ signal) and is also associated with low 
lipid accumulation in mature adipocytes [63].
Some studies revealed that vitamin D deficiency was closely associated with 
enhanced risk of major adverse cardiovascular diseases (CVD) [64, 65]. Some trials 
revealed a tendency toward a decrease in CVD risk with vitamin D supplementation 
as well, but the correlation was not significant [66]. Observational studies have 
indicated that high 25-hydroxyvitamin D [25(OH)D] levels were associated with a 
favorable serum lipid profile [67]. However, a solid rationale for such association 
is hard to identify unless there is an effect of vitamin D supplementation on serum 
lipids in placebo-controlled randomized trials. Unfortunately, the intervention 
studies gave different results ranging from positive to negative effect [67].
However, some randomized controlled trials (RCTs) studying the effect of 
supplementation on weight loss in overweight or obese people showed inconsistent 
results [68].
5. Conclusions
As long as vitamin D deficiency is prevalent in many parts of the world and the 
supplements are an affordable option, the deficiency of vitamin D may be a com-
mon and easily treatable risk factor for several health issues including obesity, but 
further studies are required to address different confounding factors and vari-
abilities especially prospective studies to study the causal relationship between the 
deficiency of this vitamin and obesity as well as focus on the safety as well as the 
required dose regimen. Strong well-structured studies with limited confounding 
factors that will result in clear data interpretation will contribute to the future plan-
ning of health policies and guidelines used by healthcare professionals.
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